West Indies skipper Holder banned for 2nd test v New Zealand


Brathwaite - who begun Monday on 79 - misjudged the pace of Santner's delivery to be trapped lbw in the 80th over following a successful review after New Zealand's appeals were initially turned down - falling nine runs short of a century.

The West Indies resumed yesterday at 214 for two in their second innings, looking to knock off their 386-run deficit with minimal damage.

Black Caps bowler Tim Southee will rejoin New Zealand squad for the second cricket Test against the West Indies in Hamilton. But the resistance ended with the loss of Kraigg Brathwaite for 91 inside the first hour as three wickets fell before lunch.

Death Stranding and Kojima coming to The Game Awards 2017
Thanks to a cast of stars and a slew of reveals, this year's The Game Awards celebration is shaping up to be pretty substantial. Hosted by Geoff Keighley, the Game Awards 2017 looks odds on to feature Hideo Kojima's Death Stranding .

Southee, who replaces George Worker in the squad, missed the first Test following the birth of his first child.

Final scores in the match: West Indies 134 & 319; New Zealand 520-9.

Captain Kane Williamson described Blundell as brilliant in his debut.

Pope says his defence of Rohingya got through in Burma
However, "I described the situation" publicly, knowing "I could go further in the private meetings" with government officials. A Rohingya refugee man wipes his eyes, as he waits to meet Pope Francis, during an inter-religious conference at St.

On 273 for five, debutant Sunil Ambris (18) and wicketkeeper Shane Dowrich (3) steered West Indies to lunch on 286 without further loss, but the innings quickly unraveled thereafter.

The second test starts Saturday in Hamilton.

The end came swiftly for the Windies as Kemar Roach was hit plumb in front by de Grandhomme for seven, captain Jason Holder (7) miscued a pull at Wagner and was taken at square leg and Miguel Cummins was bowled by Boult for 14.

Biocon surgest 15% on USFDA approval
Mylan has become the first pharma company to win United States approval for a biosimilar of Roche's big-selling cancer antibody Herceptin .